ArticleRadiology. Imaging cancer2026
Lipidomic Profiling of Rabbit VX2 Tumors Using Matrix-assisted Laser Desorption Ionization Mass Spectrometry Imaging.
Article in Radiology. Imaging cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Purpose To characterize lipidomic profiles in the VX2 rabbit tumor model and assess potential lipid plasticity across tumor microenvironments in the liver and flank. Materials and Methods VX2 tumors were implanted into the liver in four rabbits and both flanks in two rabbits. After 10-14 days, tumor-containing tissues were harvested, snap frozen, sectioned, and analyzed using matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI-MSI) in both positive and negative ion modes. Tandem mass spectrometry was used for further characterization. Lipid identities were determined based on accurate mass, fragmentation patterns, and database matching. Molecular ion distributions were spatially correlated with hematoxylin-eosin-stained sections. Results MALDI-MSI revealed distinct lipidomic profiles between liver and flank tumors. Oleate (mass-to-charge ratio [m/z] 281.24) was consistently localized to viable tumor regions in both sites. Phosphatidic acid 18:0/18:1(m/z 701.51) was detected in only liver tumors, whereas phosphatidylinositol 18:2/18:0 (m/z 861.55) was prominent in flank tumors but absent from liver tumors, despite being present in surrounding healthy parenchyma. Phosphatidylcholine (PC) species, notably PC 34:1 (m/z 798.52) and PC 36:2 (m/z 808.56), and PC (P-36:2) (m/z 824.56), showed heterogeneous spatial distributions across both anatomic sites. Conclusion MALDI-MSI enabled spatial mapping of lipid distributions within VX2 tumors, revealing both shared and site-specific alterations. These findings reveal heterogeneous spatial lipid distributions in the VX2 model and may reflect microenvironment-driven lipid plasticity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.